Clinical Operations & Patient Safety · Healthcare & Life Sciences
Should you build or buy Device Connectivity & Biometric Data Aggregation (API)?
Device connectivity and biometric data aggregation APIs provide normalized, real-time data feeds from consumer wearables, clinical-grade remote monitoring devices, and point-of-care sensors into healthcare applications. These platforms maintain certified integrations with hundreds of device manufacturers, handling authentication, data normalization, and FHIR-compliant output so health systems and digital health developers can build monitoring workflows without managing individual device SDKs.
The build-vs-buy decision for Device Connectivity & Biometric Data Aggregation APIs turns on whether maintaining hundreds of live device integrations — with their ongoing certification cycles and vendor relationship management — is work your engineering team should own, or whether the intelligence you want to build lives above the connectivity layer and should be kept separate from it; the specifics decide it.
Build it, buy it, or bridge?
When building makes sense
Building your own device connectivity and biometric data aggregation layer is not a realistic path for any organization at scale. The challenge is not the API architecture — that part is straightforward — but the ongoing maintenance of live, certified integrations with hundreds of consumer and clinical device manufacturers. Each device type requires its own SDK integration, and as manufacturers release firmware updates or change their authentication models, those integrations break and need to be repaired. No internal engineering team has replicated the integration breadth of vendors like Validic or Human API in production, because the work is entirely in ongoing maintenance rather than initial development. The building opportunity in this space is the layer above connectivity: remote monitoring program logic, patient stratification, predictive models trained on normalized biometric feeds. That work belongs to your team and creates genuine differentiation. Connectivity itself is the plumbing that enables it.
When buying makes sense
Buying device connectivity makes sense for any organization running remote patient monitoring programs across more than a handful of device types. Vendors like Validic, Human API, and Redox have built and maintained the certified integration library that makes multi-device RPM programs operationally feasible. The practical value isn't technical sophistication — it's that the vendor relationship management, SDK update cycles, and recertification work are handled outside your engineering organization. What you're purchasing is the ability to add new device types to your monitoring program without a new engineering project for each one. For digital health companies building RPM applications, buying connectivity infrastructure and focusing engineering capacity on the application layer is the architecture that scales. The decision calculus is unusually clean here: connectivity is commodity, and the biometric intelligence you build on top of it is where your value lives.
The desk read
The value proposition for vendors like Validic and Human API isn't the technology, it's the library. Maintaining live, certified integrations with 500+ consumer and clinical devices requires constant vendor relationship management, SDK updates, and certification cycles that have no connection to your core clinical mission. No internal engineering team has replicated that breadth in production because the work is entirely in the ongoing maintenance, not the initial build.
AI hasn't changed this calculus much. The emerging action is using aggregated biometric feeds to power remote patient monitoring workflows and predictive models, and that's where your internal team's energy belongs. Connectivity itself is commodity infrastructure. Buying from a device aggregation layer and then building intelligence on top of the cleaned, normalized feed is the cleaner split of effort.
Frequently asked
What is Device Connectivity & Biometric Data Aggregation (API)?
Device connectivity and biometric data aggregation APIs provide normalized, real-time data feeds from consumer wearables, clinical-grade remote monitoring devices, and point-of-care sensors into healthcare applications. These platforms maintain certified integrations with hundreds of device manufacturers, handling authentication, data normalization, and FHIR-compliant output so health systems and digital health developers can build monitoring workflows without managing individual device SDKs.
When does building Device Connectivity & Biometric Data Aggregation make sense?
Building the integration layer itself is not realistic at scale — the ongoing certification and SDK maintenance for hundreds of devices has no connection to your clinical mission. The building opportunity is in the RPM program logic, patient stratification, and predictive models that sit above the connectivity layer.
When does buying Device Connectivity & Biometric Data Aggregation make sense?
Buying makes sense for any organization running multi-device RPM programs. Vendors carry the device relationship management, certification cycles, and SDK maintenance that allow you to add new device types without new engineering projects for each one.
What are the main Device Connectivity & Biometric Data Aggregation vendors?
Representative vendors include Validic, Human API, Redox (device/data integration), Xealth. B4 Pro scores the full set.
How does FHIR compliance affect device connectivity choices?
FHIR (Fast Healthcare Interoperability Resources) is the dominant standard for exchanging healthcare data, and most EHR and care management platforms expect data in FHIR-compliant formats. Device aggregation vendors that normalize biometric data to FHIR resources simplify EHR integration significantly — without that normalization layer, each device type would require custom translation work before its data could flow into clinical workflows.